trump rx glp-1 weight loss drugs will now be covered by Medicare and Medicaid—and available at a discount through TrumpRx White House launches discount drug
Description
The observed GLP-1R/GIPR dual activity is particularly similar to that of tirzepatide, a clinically approved dual incretin agonist (Jastreboff A et al., 2022)
Say goodbye to digestive issues, occasional bloating and irregularity, and say hello to a happy gut with Gut Response GLP-1
The internal conversation around food starts changing
These results provide clinical proof-of-concept for CT-388 and validation of the CE platform
How much do weight-loss medications cost
